rs1057517809
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Analysis of protein-coding genetic variation in 60,706 humans.
|
27535533 |
2016 |
rs1057519368
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Analysis of protein-coding genetic variation in 60,706 humans.
|
27535533 |
2016 |
rs1057519368
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1057519368
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.
|
28086757 |
2017 |
rs1057519724
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Analysis of protein-coding genetic variation in 60,706 humans.
|
27535533 |
2016 |
rs1057519724
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships.
|
29706350 |
2018 |
rs1057520208
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1057520900
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1060500110
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.
|
21194675 |
2011 |
rs1060500110
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.
|
20712882 |
2010 |
rs1060500110
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1060500110
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
|
11238682 |
2001 |
rs1060500110
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
|
9467011 |
1998 |
rs1060500113
|
|
AT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1060500114
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1060500115
|
|
CT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1060500116
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1060500124
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1060500126
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.
|
23399955 |
2013 |
rs1060500126
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
|
17942903 |
2007 |
rs1060500126
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Increased PI3K/Akt activity and deregulated humoral immune response in human PTEN deficiency.
|
27531073 |
2016 |
rs1060500126
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.
|
21194675 |
2011 |
rs1060500126
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1060500126
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
|
10866302 |
2000 |
rs1060500126
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Retinal angioma in a patient with Cowden disease.
|
12614768 |
2003 |